Inventor
FORDYCE EUAN ALEXANDER FRASER
GB20 patents
⚠️ This page may combine multiple inventors who share the name “FORDYCE EUAN ALEXANDER FRASER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
RESPIVERT LTD
9 patentsUS9624196B2Apr 18, 2017
Inhibitor of p38 MAP kinase
RESPIVERT LTD15 citations92
US9447076B2Sep 20, 2016
Inhibitor of p38 map kinase
RESPIVERT LTD16 citations92
US9701670B2Jul 11, 2017
Pyrazolyl-ureas as kinase inhibitors
RESPIVERT LTD10 citations80
US10294216B2May 21, 2019
Pyrazolyl ureas as kinase inhibitors
RESPIVERT LTD1 citations72
US11634406B2Apr 25, 2023
Inhibitor of p38 MAP kinase
RESPIVERT LTD0 citations62
US11142515B2Oct 12, 2021
Pyrazolyl-ureas as kinase inhibitors
RESPIVERT LTD0 citations61
US9884845B2Feb 6, 2018
Pyrazolyl-ureas as kinase inhibitors
RESPIVERT LTD1 citations61
US10815217B2Oct 27, 2020
Inhibitor of p38 MAP kinase
RESPIVERT LTD0 citations51
US10045980B2Aug 14, 2018
Inhibitor of p38 map kinase
RESPIVERT LTD0 citations51
PULMOCIDE LTD
6 patentsUS10035810B2Jul 31, 2018
5,6-dihydro-4H-benzo[b]thieno-[2,3-d]azepine derivative
PULMOCIDE LTD2 citations72
US10189863B2Jan 29, 2019
5,6-dihydro-4H-benzo[b]thieno-[2,3-d]azepine derivatives
PULMOCIDE LTD3 citations71
US10472375B2Nov 12, 2019
5,6-dihydro-4H-benzo[b]thieno-[2,3-d]azepine derivative
PULMOCIDE LTD0 citations50
US10273249B2Apr 30, 2019
5,6-dihydro-4H-benzo[b]thieno-[2,3-d]azepine derivative
PULMOCIDE LTD0 citations50
US10160772B2Dec 25, 2018
5,6-dihydro-4H-benzo[b]thieno-[2,3-d]azepine derivatives
PULMOCIDE LTD0 citations40
US10626126B2Apr 21, 2020
Compounds
PULMOCIDE LTD0 citations38
CANCER RESEARCH TECH LTD
4 patentsUS10954241B2Mar 23, 2021
Heterocyclic compounds as ret kinase inhibitors
CANCER RESEARCH TECH LTD3 citations71
US10844067B2Nov 24, 2020
Heterocyclic compounds as RET kinase inhibitors
CANCER RESEARCH TECH LTD4 citations71
US11661423B2May 30, 2023
Heterocyclic compounds as RET kinase inhibitors
CANCER RESEARCH TECH LTD1 citations60
US11548896B2Jan 10, 2023
Heterocyclic compounds as RET kinase inhibitors
CANCER RESEARCH TECH LTD1 citations60